Introducing the CareStart COVID-19 Antigen Home Test – Your Fast, Accurate, and User-Friendly Testing Solution
Navigate the challenges of the COVID-19 pandemic with confidence using the CareStart COVID-19 Antigen Home Test, a lateral flow immunoassay designed for rapid and qualitative detection of the SARS-CoV-2 nucleocapsid protein antigens. Authorized for emergency use by the FDA, this self-test kit enables individuals aged 14 and older, as well as adults testing children as young as 2 years, to easily detect COVID-19 symptoms within the first 7 days of symptom onset. Moreover, it offers the flexibility to test individuals with or without symptoms or other epidemiological reasons to suspect COVID-19, ensuring comprehensive coverage and peace of mind.
Key Features:
-
FDA EUA Authorized: Provides a trustworthy testing option under the FDA's Emergency Use Authorization.
-
Versatile Testing Capability: Suitable for individuals aged 14 years and older for self-collection and 2 years and older with adult assistance.
-
Rapid Results: Delivers results in just 10 minutes, allowing for quick decision-making and peace of mind.
-
Easy-to-Interpret Results: Leverages a mobile application for straightforward result interpretation, compatible with iOS13 or newer and Android10 or newer devices.
Product Details:
-
Convenient Self-Testing: Offers a simple testing process at home or any preferred location without the need for professional assistance.
-
Kit Components: Each kit includes test devices, extraction vials and caps, nasal swabs, and user instructions with a fact sheet for individuals.
-
Order Information: Available in various package units for individual or multiple tests, accommodating different testing needs.
-
Reliable Detection: Qualitatively detects SARS-CoV-2 nucleocapsid protein, identifying current infection status efficiently.
Special Offers:
If you are interested in purchasing our products with a lower price and special discounts. Please contact sales@cetrixstore.com for more information and to discuss your needs.